Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumorsCentral MessagePerspective by Terrance Peng, MD, MPH, Sean C. Wightman, MD, Li Ding, MD, MPH, Dustin K. Lieu, MD, Scott M. Atay, MD, Elizabeth A. David, MD, MAS, Anthony W. Kim, MD

Get full text

The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screeningCentral MessagePerspective by Nanruoyi Zhou, MD, John Deng, BS, Claire Faltermeier, MD, PhD, Terrance Peng, MD, MPH, Hanna Mandl, BS, Sha'shonda Revels, MD, MS, Paul Toste, MD, Robert B. Cameron, MD, Jay M. Lee, MD, Jane Yanagawa, MD

Get full text